Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by Atria Investments Inc

Atria Investments Inc reduced its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 31.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 29,545 shares of the company’s stock after selling 13,731 shares during the quarter. Atria Investments Inc’s holdings in Ryan Specialty were worth $1,962,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of RYAN. Securian Asset Management Inc. bought a new stake in shares of Ryan Specialty in the 2nd quarter worth $474,000. Xponance Inc. lifted its holdings in Ryan Specialty by 67.2% in the 2nd quarter. Xponance Inc. now owns 20,686 shares of the company’s stock valued at $1,198,000 after acquiring an additional 8,312 shares during the last quarter. Geneva Partners LLC bought a new position in shares of Ryan Specialty during the 3rd quarter valued at about $2,537,000. Susquehanna Fundamental Investments LLC grew its stake in shares of Ryan Specialty by 2,354.0% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 100,614 shares of the company’s stock worth $5,827,000 after purchasing an additional 96,514 shares during the last quarter. Finally, Retirement Systems of Alabama bought a new stake in shares of Ryan Specialty in the 2nd quarter worth approximately $7,316,000. Institutional investors own 84.82% of the company’s stock.

Insider Buying and Selling

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the business’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $65.15, for a total transaction of $2,280,250.00. Following the completion of the transaction, the director now owns 9,115 shares of the company’s stock, valued at approximately $593,842.25. The trade was a 79.34 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Mark Stephen Katz sold 14,790 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $71.39, for a total value of $1,055,858.10. Following the sale, the executive vice president now owns 12,386 shares of the company’s stock, valued at approximately $884,236.54. The trade was a 54.42 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 94,193 shares of company stock worth $6,208,493. 11.10% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. JPMorgan Chase & Co. upped their price target on Ryan Specialty from $54.00 to $56.00 and gave the company an “underweight” rating in a report on Friday, August 2nd. The Goldman Sachs Group upped their target price on Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a report on Wednesday, October 9th. Wells Fargo & Company lifted their price target on Ryan Specialty from $63.00 to $70.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 10th. BMO Capital Markets raised shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and upped their price objective for the company from $65.00 to $75.00 in a research note on Tuesday, September 24th. Finally, Bank of America lifted their target price on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Ryan Specialty currently has a consensus rating of “Hold” and an average target price of $70.33.

Ryan Specialty Stock Performance

RYAN stock opened at $70.88 on Friday. The firm has a 50 day moving average of $68.14 and a two-hundred day moving average of $61.66. Ryan Specialty Holdings, Inc. has a 12 month low of $41.49 and a 12 month high of $73.10. The company has a market capitalization of $18.56 billion, a price-to-earnings ratio of 92.05, a P/E/G ratio of 1.63 and a beta of 0.62. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The firm had revenue of $604.69 million during the quarter, compared to analysts’ expectations of $602.04 million. During the same period in the prior year, the company posted $0.32 earnings per share. Ryan Specialty’s revenue for the quarter was up 20.5% on a year-over-year basis. As a group, equities analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th will be paid a $0.11 dividend. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.62%. The ex-dividend date of this dividend is Tuesday, November 12th. Ryan Specialty’s payout ratio is 57.14%.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.